Thomas Kahan

59.9k total citations · 2 hit papers
260 papers, 6.9k citations indexed

About

Thomas Kahan is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Thomas Kahan has authored 260 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Cardiology and Cardiovascular Medicine, 33 papers in Endocrinology, Diabetes and Metabolism and 31 papers in Surgery. Recurrent topics in Thomas Kahan's work include Blood Pressure and Hypertension Studies (102 papers), Heart Rate Variability and Autonomic Control (45 papers) and Cardiovascular Function and Risk Factors (31 papers). Thomas Kahan is often cited by papers focused on Blood Pressure and Hypertension Studies (102 papers), Heart Rate Variability and Autonomic Control (45 papers) and Cardiovascular Function and Risk Factors (31 papers). Thomas Kahan collaborates with scholars based in Sweden, United Kingdom and Italy. Thomas Kahan's co-authors include Paul Hjemdahl, Maud Daleskog, Karin Malmqvist, Ann Charlotte Laska, Veronica Murray, Lars Lind, Magnus von Arbin, Björn Wettermark, Fredrik H. Nyström and Märit Mejhert and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Thomas Kahan

251 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: Comparison with a radioenzymatic method

1979 527 citations Paul Hjemdahl, Thomas Kahan et al. profile →
Sex differences in arterial hypertension

2022 118 citations Claudio Borghi, Thomas Kahan et al. European Heart Journal profile →

Peers

Countries citing papers authored by Thomas Kahan

Since Specialization

Citations

This map shows the geographic impact of Thomas Kahan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kahan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kahan more than expected).

Fields of papers citing papers by Thomas Kahan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kahan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kahan. The network helps show where Thomas Kahan may publish in the future.

Co-authorship network of co-authors of Thomas Kahan

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kahan. A scholar is included among the top collaborators of Thomas Kahan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kahan. Thomas Kahan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patient Perspectives on Digital Technology and Experiences of Computerized History-Taking for Chest Pain Management in the Emergency Department: CLEOS-CPDS Prospective Cohort Study 2025 ·JMIR Medical Informatics ·(unknown), (unknown), Jonas Spaak, Sabine Koch, Carl Johan Sundberg, David Zakim, Thomas Kahan, Kay Sundberg	0
2	The definition of treatment assignment in observational emulations of target trials – an empirical examination in the Swedish Primary Care Cardiovascular Database 2025 ·Annals of Epidemiology ·(unknown), Anthony Matthews, Jessica L Young, Anita Berglund, Bertil Lindahl, Björn Wettermark, Issa J Dahabreh, Thomas Kahan, Miguel A. Hernán	0
3	Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Sweden 2025 ·Blood Pressure ·Thomas Kahan, (unknown), (unknown), (unknown), (unknown), Peter Lindgren, Jan B. Pietzsch	0
4	Are medical history data fit for risk stratification of patients with chest pain in emergency care? Comparing data collected from patients using computerized history taking with data documented by physicians in the electronic health record in the CLEOS-CPDS prospective cohort study 2024 ·Journal of the American Medical Informatics Association ·(unknown), Carl Johan Sundberg, Jonas Spaak, Sabine Koch, Thomas Kahan	4
5	Lack of associations between hospital rating and outcomes in patients with an acute coronary syndrome 2024 ·BMJ Open Quality ·Sara Aspberg, Thomas Kahan, Fredrik Johansson	1
6	Performance of computerized self-reported medical history taking and HEAR score for safe early rule-out of cardiac events in acute chest pain patients: the CLEOS-CPDS prospective cohort study 2024 ·European Heart Journal - Digital Health ·(unknown), (unknown), Carl Johan Sundberg, Sabine Koch, Jonas Spaak, Thomas Kahan	1
7	Associations between inflammatory and angiogenic proteomic biomarkers, and cardiovascular events and mortality in relation to kidney function 2024 ·Clinical Kidney Journal ·(unknown), (unknown), Marie Evans, (unknown), Håkan Wallén, Tomas Jernberg, Thomas Kahan, Pia Lundman, Per Tornvall, David Erlinge, Bertil Lindahl, Tomasz Baron, Melinda Rezeli, Jonas Spaak, Stefan H. Jacobson	2
8	Long-term secondary prevention and outcome following acute coronary syndrome: real-world results from the Swedish Primary Care Cardiovascular Database 2023 ·European Journal of Preventive Cardiology ·(unknown), Charlotta Ljungman, Per Hjerpe, Linus Schiöler, (unknown), Kristina Bengtsson Boström, Thomas Kahan, (unknown)	3
9	Open Up your Science in EHJ Open 2021 ·European Heart Journal Open ·Magnus Bäck, Maciej Banach, Frieder Braunschweig, Salvatore De Rosa, Alessia Gimelli, Thomas Kahan, Daniel F.J. Ketelhuth, Patrizio Lancellotti, Susanna C. Larsson, Linda Mellbin, Edit Nagy, Gianluigi Savarese, Karolina Szummer, Denis Wahl, (unknown)	0
10	Use of Self-Reported Computerized Medical History Taking for Acute Chest Pain in the Emergency Department – the Clinical Expert Operating System Chest Pain Danderyd Study (CLEOS-CPDS): Prospective Cohort Study 2021 ·Journal of Medical Internet Research ·(unknown), Carl Johan Sundberg, Jonas Spaak, Sabine Koch, David Zakim, Thomas Kahan	11
11	ECG-monitoring of in-hospital cardiac arrest and factors associated with survival 2020 ·Resuscitation ·Anna Thorén, Araz Rawshani, Johan Herlitz, Johan Engdahl, Thomas Kahan, Linnéa Gustafsson, Therese Djärv	25
12	A prospective cohort study of self-reported computerised medical history taking for acute chest pain: protocol of the CLEOS-Chest Pain Danderyd Study (CLEOS-CPDS) 2020 ·BMJ Open ·(unknown), Thomas Kahan, Jonas Spaak, Kay Sundberg, Sabine Koch, (unknown), Carl Johan Sundberg, David Zakim	11
13	Use of proteomics to identify biomarkers associated with chronic kidney disease and long‐term outcomes in patients with myocardial infarction 2020 ·Journal of Internal Medicine ·Robert Edfors, Lars Lindhagen, Jonas Spaak, Marie Evans, Pontus Andell, Tomasz Baron, (unknown), Melinda Rezeli, (unknown), Pia Lundman, Karolina Szummer, Per Tornvall, Håkan Wallén, Stefan H. Jacobson, Thomas Kahan, György Marko‐Varga, David Erlinge, Stefan James, Bertil Lindahl, Tomas Jernberg	8
14	Oscillometrically Measured Aortic Pulse Wave Velocity Reveals Asymptomatic Carotid Atherosclerosis in a Middle‐Aged, Apparently Healthy Population 2020 ·BioMed Research International ·(unknown), Béla Benczúr, Veronika Müller, András Bikov, Andrea Székely, Thomas Kahan, Zsófia Lenkey, (unknown), Attila Cziráki, Miklós Illyés	6
15	Nutraceuticals and blood pressure control: a European Society of Hypertension position document 2020 ·Journal of Hypertension ·Claudio Borghi, Konstantinos Tsioufis, Enrico Agabiti‐Rosei, Michel Burnier, Arrigo F.G. Cicero, Denis Clément, António Coca, Giovambattista Desideri, Guıdo Grassı, Dragan Lović, Empar Lurbe, Thomas Kahan, Reinhold Kreutz, Bojan Jelaković, Jorge Polónia, Josep Redón, Philippe van de Borne, Giuseppe Mancia	50
16	The effects of alpha 1-adrenoceptor blockade and angiotensin converting enzyme inhibition on central and brachial blood pressure and vascular reactivity: the doxazosin–ramipril study 2016 ·Heart and Vessels ·(unknown), Majid Kalani, Thomas Kahan	16
17	Hyperresponders vs. nonresponder patients after renal denervation 2014 ·Journal of Hypertension ·Alexandre Persu, Michel Azizi, Yu Jin, Sebastian Völz, J. Rosa, Fadl Elmula M. Fadl Elmula, Antoinette Péchère-Bertschi, Michel Burnier, Patrick B. Mark, Arif Elvan, Jean Renkin, Marc Sapoval, Thomas Kahan, Sverre E. Kjeldsen, Jan A. Staessen	24
18	The Epidemiology of Heart Failure, Based on Data for 2.1 Million Inhabitants in Sweden 2013 ·European Journal of Heart Failure ·(unknown), Björn Wettermark, Per Wändell, Märit Mejhert, Robert Szulkin, Gunnar Ljunggren, Thomas Kahan	222
19	Transforming growth factor β₁genotype and change in left ventricular mass during antihypertensive treatment–results from the swedish irbesartan left ventricular hypertrophy investigation versus atenolol (Silvhia) 2004 ·Clinical Cardiology ·Pär Hallberg, Lars Lind, (unknown), Karl Michaëlsson, Julia Karlsson, Lisa Kurland, Thomas Kahan, Karin Malmqvist, K. Peter Öhman, Fredrik H. Nyström, Ulrika Liljedahl, Ann‐Christine Syvänen, Håkan Melhus	9
20	The effects of adenosine as adjuvant therapy in acute myocardial infarction on cardiovascular events. Results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study 2001 ·European Heart Journal ·Miguel Quintana, Alf Sollevi, Nina Rehnqvist, Thomas Kahan, Magnus Edner, Eva Swahn, Per Näsman, (unknown), Paul Hjemdahl	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact